COL5A1 and bladder transitional cell carcinoma: These results may have implications for cancer ICB and chemotherapy, for example, BLCA patients with high COL5A1 expression may have a more sensitive response to cisplatin treatment, which may provide accurate treatment protocols for chemotherapy.